Lumida
/NVS
⌘K
Novartis AG

Novartis AG

NVS
$137.16USD-0.23%-0.32 today

MARKET CAP

166.9B

P/E (TTM)

15.8x

FWD P/E

14.3x

DAY RANGE

$137 – $140

52W RANGE

$122
$170
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$44.0B$43.5B$46.7B$51.7B$56.7B
YoY %-11.9%-1.2%+7.4%+10.8%+9.6%
P / Sales
EV / Sales
Gross Profit, Adj.$32.2B$31.9B$34.2B$38.9B$43.0B
YoY %-7.3%-1.1%+7.2%+13.8%+10.5%
Margin %73.3%73.4%73.3%75.2%75.8%
EV / Gross Profit
EBITDA, Adj.$10.1B$7.9B$8.0B$13.4B$16.2B
YoY %-0.9%-21.0%+0.6%+67.2%+21.1%
Margin %22.9%18.3%17.1%25.8%28.6%
EV / EBITDA
EBIT$10.1B$7.9B$8.0B$13.4B$16.2B
YoY %-0.9%-21.0%+0.6%+67.2%+21.1%
Margin %22.9%18.3%17.1%25.8%28.6%
EV / EBIT
Net Income$24.0B$7.0B$14.8B$11.9B$14.0B
YoY %+197.6%-71.0%+113.5%-19.6%+17.1%
Net Margin54.6%16.0%31.8%23.1%24.7%
EPS (GAAP)$10.63$3.17$7.10$5.87$7.15
YoY %+202.0%-70.2%+124.0%-17.3%+21.8%